darolutamide 300 MG Oral Tablet [Nubeqa]

RxNorm concept 2180336, branded drug (sbd). Prescribable name: NUBEQA 300 MG Oral Tablet.

RxCUI: 2180336
Term type: Branded drug (SBD)
Status: Active

Request

curl https://api.healthcare.dev/v1/drugs/rxnorm/2180336 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Concept

Ingredients and related concepts

Ingredients

darolutamide 2180325

Other names

Nubeqa 300 MG Oral Tablet

Related concepts

darolutamide 300 MG (SCDC, consists of)
darolutamide 300 MG [Nubeqa] (SBDC, consists of)
Oral Tablet (DF, has dose form)
Nubeqa (BN, has ingredient)
darolutamide 300 MG Oral Tablet (SCD, tradename of)

Linked data

NDCs

NDC-11s RxNorm links to this concept; linked ones open their FDA product.

Use it

Look up 2180336 from code or an agent

curl

curl https://api.healthcare.dev/v1/drugs/rxnorm/2180336 \
  -H "Authorization: Bearer $HDEV_API_KEY"

MCP prompt

Using the healthcare.dev MCP server, look up RxNorm concept 2180336. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.

Get a free key RxNorm docs Connect the MCP server

Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.